GSK, XenoPort part ways after Horizant disappointment – FiercePharma

by admin on November 10, 2012

GSK, XenoPort part ways after Horizant disappointment
FiercePharma
The U.K.-based drugmaker is kicking the restless legs syndrome drug back to partner XenoPort after a series of setbacks, including disappointing sales and a partnership dispute. Horizant hasn't performed up to either company's expectations. Its road to

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: